Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2010; 55:502-503, doi:10.1016/j.jacc.2009.10.025
© 2010 by the American College of Cardiology Foundation
This Article
Right arrow Full Text (PDF)
Right arrow Correction (v55,p1401)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Veyrat, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Veyrat, C.
Related Collections
Right arrowRelated Article

CORRESPONDENCE: LETTER TO THE EDITOR

Pierre Soulié, a "Pre-Echocardiographic" Pioneer of Hypertrophic Cardiomyopathy

Colette Veyrat, MD*

* Institut Mutualiste de Montsouris, Department of Cardiovascular Medicine, 42, Boulevard Jourdan, Paris, Ile de France 75674, France (Email: colette.veyrat.resedal{at}noos.fr).


Maron et al. (1) recently issued an in-depth review of evolving concepts for hypertrophic cardiomyopathy. These prestigious investigators report the concordant or controversial issues discussed over 50 years. They finally present an understanding of the disease consistent with the early descriptions.

I understand that the report is clearly dedicated to the evolving opinions and debates generated by the disease in the last 50 years. I also am well aware of the decisive contribution of echocardiography for understanding its mechanism since 1969 and of the value of genetics for the study of the transmission of the disease and its heterogeneous clinical spectra. Nevertheless, grouping important contributions of researchers who deciphered its early characteristic features from 1957 to about 1967 under the nonspecific "pre-echocardiographic" era, in the way historians refer to the B.C. period, is at risk to overlook some pioneers.

In the late 1950s, namely from 1957 to 1959, all the cards were not in the same hands to diagnose hypertrophic cardiomyopathy; on the one hand, when looking at ventricular walls, it was on arrested heart for surgeons (2) or at necropsy for anatomists. This enabled the discovery of asymmetrical septal hypertrophy (3), but the dynamic features lacked the ability necessary to recognize the disease; the global hypertrophy found at surgery or necropsy was interpreted as residual in the outflow tract after reduction of a valvular or subvalvular membranous stenosis or secondary to systemic hypertension, or of unknown origin (2,4–5). On the other hand, those studying the beating heart with their mere ears, fingers, and stethoscopes did not "see" the underlying cardiac structures' abnormalities and attributed the murmurs they heard to rheumatic aortic stenoses, which were the rule. Titles of papers reflect their astonishment (2,4–6). In 1958, Pierre Soulié was the first to link asymmetrical septal hypertrophy, subvalvular pressure gradient, and the typical arterial pattern in the new concept of a "true subvalvular muscular stenosis" in a paper presented at the French Society of Cardiology (October 19, 1958). Detailed findings were printed later in September 1959 (6). Typical features of the arterial pressure tracings were shown and detailed: initial rapid upstroke followed by a lower prolonged tidal wave accounting for the hindrance to flow due to the "nonpermanent systolic muscular obstruction." He emphasized its diagnostic value versus valvular stenosis. Although Brock (2) had vaguely noted such a transitory pattern on some contractions without drawing any diagnostic information (Fig. 11 in Brock [2]), confirmation of the arterial pattern came from Brachfeld and Gorlin's later review (7).

Reading Soulié's paper shows an obvious observational advance over previous references (2,4,5). Finally, Soulié's hypothesis about the septal subvalvular site of the murmur was later substantiated by intracardiac phonocardiography (8). Similar features were found on flow velocity traces in the aorta (9) and later transcutaneously (10).

Rapidly improving invasive procedures added complementary information at the end of this "pre-echocardiographic" era. The stage was, thus, ready for echocardiographic and genetic studies to complement the whole spectrum of the disease.


    References
 Top
 References
 
1. Maron BJ, Maron MS, Wigle ED, Braunwald E. The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy J Am Coll Cardiol 2009;54:191-200.[Abstract/Free Full Text]

2. Brock RC. Functional obstruction of the left ventricle (acquired aortic subvalvular stenosis) Guys Hosp Rep 1957;106:221-238.[Medline]

3. Teare D. Asymmetrical hypertrophy of the heart in young adults Brit Heart J 1958;20:1-8.[Free Full Text]

4. Bercu BA, Diettert GA, Danforth WH, Pund EE, Ahlvin RC, Belliveau RR. Pseudo stenosis produced by ventricular hypertrophy Am J Med 1958;25:814-818.[CrossRef][Web of Science][Medline]

5. Morrow A, Braunwald E. Functional aortic stenosis: a malformation characterized by resistance to left ventricular outflow without anatomic obstruction Circulation 1959;20:181-189.[Abstract/Free Full Text]

6. Soulié P, Degeorges M, Joly F, Caramanian M, Carlotti J. [A cause of error in the hemodynamic diagnosis of aortic stenosis] Arch Mal Coeur Vaiss 1959;52:1002-1019.[Medline]

7. Brachfeld N, Gorlin R. Subaortic stenosis: a revised concept of the disease Medicine 1959;38:415-433.[Medline]

8. Soulié P, Forman J, Delzant JF, Duperier CL, Varin G. [Muscular stenosis of the left ventricle. Hemodynamics and intracardiac phonocardiography (à propos of 35 cases)] Arch Mal Coeur Vaiss 1967;60:1-32.[Medline]

9. Hernandez RR, Greenfield JC, McCall B. Pressure-flow studies in hypertrophic subaortic stenosis J Clin Invest 1964;43:401-407.[CrossRef][Web of Science][Medline]

10. Kalmanson D, Veyrat C. [Diagnostic value of transcutaneous arterial flow traces in cardiovascular diseases] Clinique 1969;64:257-261.


Related Article

The 50-Year History, Controversy, and Clinical Implications of Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy: From Idiopathic Hypertrophic Subaortic Stenosis to Hypertrophic Cardiomyopathy
Barry J. Maron, Martin S. Maron, E. Douglas Wigle, and Eugene Braunwald
J. Am. Coll. Cardiol. 2009 54: 191-200. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Correction (v55,p1401)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Veyrat, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Veyrat, C.
Related Collections
Right arrowRelated Article

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement